Skip to content
SwAPP

SwAPP

Swiss Association of Pharmaceutical Professionals

  • Welcome
    • Upcoming events
    • Want to join the SwAPP network
    • What’s new
  • Events
    • SwAPP events
    • Events with discounts for SwAPP members
    • SwAPP accredited events CH
    • SwAPP accredited events Europe
    • Webinars
    • Review of events
  • News
    • Register for events
    • Job adds
    • Selected regulatory news CH
    • Selected regulatory news EU/international
  • About us
    • Who we are
    • Executive board & CPD
    • By-laws
    • Membership
    • Get involved
    • Task forces
  • Membership
    • Why join?
    • Application
    • Categories
    • Fees and payment
    • Change of membership information
  • Services
    • Application for accreditation / Lists of accreditation
    • Certifications /Diploma – Life Long Learning
    • Job offers & Career development
    • Links
    • FAQ
  • Contact us
Posted on November 9, 2018December 4, 2018 by swapp

Swissmedic: Therapeutic Products Act (Stage 2)

Information about Ordinary Revision of the Therapeutic Products Act (Stage 2) and right of enforcement to enter into force on 1 January 2019.

Presentations in German

Presentations in French

CategoriesRegulatory Selected News CH

Post navigation

Previous PostPrevious FOPH: Integrity, Transparency and Obligation to pass on discounts for therapeutic products
Next PostNext EMA gives guidance on safety monitoring of medicines used in children
  
Imprint - Disclaimer

All contents © copyright 2018
SwAPP, Swiss Association of Pharmaceutical Professionals Inc.
All rights reserved.
Proudly powered by WordPress